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Background: The basis of the pathogenicity of the H50Q variant -synuclein is unknown.
Results: The critical concentration of -synuclein is decreased by 10-fold by the H50Q mutation, and its aggregation is
modulated by the wild-type isoform.
Conclusion: Key effects of the H50Q mutation on the aggregation of -synuclein can be quantified.
Significance:Our data provide insights into the mechanism of Lewy body formation in vivo.
The conversion of -synuclein from its intrinsically disor-
dered monomeric state into the fibrillar cross- aggregates
characteristically present in Lewy bodies is largely unknown.
The investigation of -synuclein variants causative of familial
forms of Parkinson disease can provide unique insights into the
conditions that promote or inhibit aggregate formation. It has
been shown recently that a newly identified pathogenic muta-
tion of-synuclein, H50Q, aggregates faster than the wild-type.
We investigate here its aggregation propensity by using a
sequence-basedprediction algorithm,NMRchemical shift anal-
ysis of secondary structure populations in the monomeric state,
anddeterminationof thermodynamic stability of the fibrils.Our
data show that the H50Q mutation induces only a small incre-
ment in polyproline II structure around the site of the mutation
and a slight increase in the overall aggregation propensity. We
also find, however, that the H50Q mutation strongly stabilizes
-synuclein fibrils by 5.0  1.0 kJ mol1, thus increasing the
supersaturation of monomeric -synuclein within the cell, and
strongly favors its aggregation process. We further show that
wild-type-synuclein can decelerate the aggregation kinetics of
the H50Q variant in a dose-dependent manner when coaggre-
gating with it. These last findings suggest that the precise bal-
ance of -synuclein synthesized from the wild-type and mutant
alleles may influence the natural history and heterogeneous
clinical phenotype of Parkinson disease.
-Synuclein (-Syn)4 is central to the pathogenesis of Par-
kinson disease (1, 2). Mutations and multiplications of the
encoding SNCA gene are associated with familial Parkinson
disease and polymorphisms with an increased risk of develop-
ing sporadic disease (3–7). Monomers of -Syn have been
shown to be capable of forming soluble oligomers and amyloid
fibrils (8–10), which are themajor component of intraneuronal
Lewy bodies, the pathological hallmark of Parkinson disease
(11, 12). The molecular basis of the transition of -Syn from its
intrinsically disordered monomeric state (13–15) into cross-
fibrillar assemblies is largely unknown. Future progress is
expected from the complementary synergy of two approaches:
continuous optimization of algorithms suitable for predicting
the aggregation propensity of the protein and the production of
experimental models of -Syn fibrillogenesis mimicking the
physiological environment. Particularly informative is the
investigation of natural pathogenic mutations of -Syn associ-
ated with misfolding and aggregation.
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The recently identified H50Q -Syn mutation (16, 17) was
shown to aggregate faster in vitro comparedwith theWTcoun-
terpart (18–21). Here we compare sequence-based predictions
of aggregation propensity (22, 23) with further experimental
observations of aggregation behavior in the WT and H50Q
-Syn. It is worth noting that in heterozygous carriers, as in the
patients with theH50Qmutation, half of the expressed-Syn is
expected to be WT. Although current aggregation propensity
algorithms are unable to predict the effect of mixtures of -Syn
variants upon the aggregation process, our experimental data
show that the WT protein attenuates the aggregation kinetics of
the variant in a dose-dependent manner. However, themolecular
explanation of the effect of H50Q and other mutations on the
aggregation propensity remains an unresolved issue.
To investigate further the causes of the increased aggregation
propensity of the H50Q variant, we characterize the mono-
meric ensembles of both WT and H50Q -Syn using NMR
spectroscopy. In previous reports, comparative spectroscopic
analyses have revealed broadly similar structural ensembles in
the WT and H50Q variants, with a small number of chemical
shift changes around the site of the mutation (18–20) and, in
some cases, additional perturbations in the C-terminal region
(18, 19). Here we carry out a comprehensive chemical shift-
based analysis of WT and H50Q -Syn, using the 2D algo-
rithm (24) to scrutinize changes in the residual secondary struc-
ture of the variant.
By recognizing that to understand the effect of a mutation it
is important to consider the potential effects on the fibrillar end
products of the aggregation process, we use chemical denatur-
ation of fibrils to determine the free energy of elongation. These
measurements provide access to the critical concentration, i.e.
the concentration above which fibrils are thermodynamically
the most stable state (25–27). Therefore, we characterize the
relative stabilities of fibrils formed from WT -Syn and the
H50Q disease-associated variant, finding that themutation has
a major impact on the solubility of the protein.
EXPERIMENTAL PROCEDURES
Aggregation Propensities with Solvent Exposure Corrections—
The intrinsic aggregation propensity profile is calculated using
the position-dependent score Piagg. For a given residue i, the
score is calculated as follows,
pi
agg hpi
h spi
shydpi
hyd (Eq. 1)
where pih and pis are the propensities for -helix and -sheet
formation, respectively, and pihyd is the hydrophobicity (23).
The values are combined to provide a score,Ziagg, that describes
the intrinsic propensity for aggregation for the whole amino
acid sequence (23, 28),
Zi
agg
1
7j33 pi jagg  patI ipat gkI igk (Eq. 2)
where Iipat is the term that takes into account the presence of
specific patterns of alternating hydrophobic and hydrophilic
residues (29), and Iigk is the term that takes into account the
gatekeeping effect of individual charges (23).
Ii
gk j1010 ci j (Eq. 3)
By combining the predictions of the intrinsic aggregation pro-
pensity profiles with those for the solvent exposure of protein
regions, it is possible to account for the influence of transient
structure formation on the aggregation propensities. The
aggregation propensity profile is defined by modulating the
intrinsic aggregation propensity profile with the CamP score,
denoted as Pi, predicting the local structural stability at that
position (30). The propensity of exposed regions to promote
aggregation can be expressed as follows,
Zi
hx Ziagg1 Pi/Pmax if Ziagg 0Ziagg if Ziagg	 0 (Eq. 4)
where Pmax 15 is a normalization constant (23). The number
of Fourier coefficients employed to obtain the results in Fig. 1 is
7 (23, 30).
Protein Expression and Purification—Recombinant WT and
H50Q variant -Syn were expressed and purified as previously
described (31). For H50Q -Syn, the QuikChange site-directed
mutagenesis kit (Stratagene) was used with the primer
sequence GAGGGAGTGGTGCAAGGTGTGGCAACAGTG
containing the underlined codon for glutamine at position 50.
Kinetics of Fibrillogenesis—Samples of recombinantWT and
H50Q -Syn, 100 
l at different concentrations (5, 10, 30, 50,
70, and 100 
M, respectively) in PBS, pH 7.4, containing 10 
M
thioflavin T (ThT) (32), were incubated at 37 °C in Costar
96-well black wall plates sealed with sealing film (4titude Gas
Permeable Moisture Barrier Seal) and subjected to 900 rpm
double orbital shaking. Bottom fluorescence was recorded at
15-min intervals (FLUOstar Omega, BMG LABTECH). Time
courses of aggregation were fitted to a sigmoidal model, as y
y0 (ymax y0)/(1 exp[kapp(t t1⁄2)]) using KaleidaGraph
4.0 (Synergy Software, Reading, PA), where y0 and ymax are the
initial andmaximumThT fluorescence, respectively; kapp is the
apparent rate constant, and lag time was defined as t1⁄2 2/kapp
(18). Experiments were conducted in triplicate in three inde-
pendent experiments. Samples containing the ThT positive
material were further analyzed by electronmicroscopy. Further
aggregation time courses were performed using mixtures of
WT/H50Q at 0:1, 1:5, 1:2, 1:1, 2:1, 5:1, and 1:0 molar ratios,
respectively, keeping the total protein concentration at 70 
M.
ElectronMicroscopy—Formvar-coated copper EMgridswere
placed coated side down onto each sample and incubated for 2
min before blotting with filter paper to remove excess solvent
and staining with 2% (w/v) uranyl acetate for 2 min. After fur-
ther blotting and drying in air, transmission electron micro-
scope (CM120) images were obtained at 80 keV.
Amyloid Fibril Preparation—A scaled up method was devel-
oped to prepare larger quantities of fibrils for further charac-
terization. Briefly, solutions ofWTandH50Q-Syn at 5mg/ml
in PBS, pH 7.4, were stirred at 1500 rpm for 72 h at 37 °C.
Finally, fibrillar aggregateswere quantified by assessment of the
monomer left in the supernatant considering that the molar
absorptivity is 5960 M1 cm1 for bothWT and variant -Syn.
Equilibrium Unfolding of WT and H50Q -Syn Fibrils—
Fibrils (0.5mg/ml) in PBS, pH 7.4, were incubatedwith increas-
ing concentrations of guanidine HCl (Merck) from 0 to 5.5 M.
Samples were thoroughly mixed by vortexing and incubated at
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room temperature for 72 h prior to centrifugation in a Beckman
OptimaTL ultracentrifuge at 135,000 g for 45min. The incu-
bation time was experimentally verified to be sufficient for the
samples to reach equilibrium, and the monomer concentration
in the supernatant was quantified as previously described (25).
Experiments were conducted in triplicate. Size exclusion chro-
matography of WT and H50Q fibrils after denaturation and
ultracentrifugation was performed using a Superdex 200 col-
umn on the A¨KTA Explorer apparatus (GE Healthcare). The
column was equilibrated and eluted at 0.5 ml/min with PBS
buffer, pH 7.4. WT and H50Q -Syn at 0.5 mg/ml in PBS were
also run as control. The fraction of soluble monomeric -Syn
over the total concentration was plotted with denaturant con-
centration for further analysis.
Determination of Thermodynamic Stability Parameters—
The equilibrium unfolding curves of -Syn fibrils were ana-
lyzed using a linear polymerization model (25, 33, 34) [Fi1]
[M]^ [Fi], inwhich [M] and [Fi] represent the concentration of
monomers and fibrillar aggregates of size i, respectively, with
the equilibrium constant K  c0[Fi]/[Fi1][M], where c0 is the
standard concentration 1 mol liter1. Based on this model the
fraction of monomeric -Syn over the total protein concentra-
tion, [M]/[MT], can be expressed as follows.
M
MT

MTK 1/2 MTK 1/4
MT
2K2
(Eq. 5)
The equilibrium constant K can also be expressed as K 
exp(Gel/RT), in which Gel is the free energy of elongation,
R is the gas constant, and T is the absolute temperature. In the
presence of chemical denaturants, i.e. guanidine HCl, Gel is
linearly dependent on the concentration of denaturant, [D],
according to Gel  m[D] Gel0, where m is a cooperativity
coefficient, and Gel0 is the free energy of elongation in the
absence of denaturants (25). The experimental data of the equi-
librium unfolding ofWT and H50Q -Syn fibrils were fitted to
Equation 5 to obtain the main thermodynamic parameters
using KaleidaGraph 4.0 (Synergy Software). Values ofmidpoint
denaturant concentration, [D]50%, and the critical concentra-
tion, ccrit c0 exp(Gel/RT), were also calculated. All measure-
ments are reported as means 	 S.D. of three independent
experiments.
Atomic Force Microscopy—After a 500-fold dilution, 10 
l of
-Syn fibrils were finally deposited on freshly cleaved mica and
dried under mild vacuum. Tapping mode AFM images were
acquired in air using a Dimension 3100 Scanning ProbeMicro-
scope and a Multimode Scanning Probe Microscope (Digital
Instruments, Bruker). Single beam uncoated silicon cantilevers
(type OMCL-AC160TS; Olympus) were used. The drive fre-
quency was between 290 and 310 kHz; the scan rate was
between 0.4 and 0.5 Hz. Fibril height was measured from the
cross-section height of topographic AFM images.
NMR Spectroscopy—NMR data were acquired at 283 K using
a 700 MHz Bruker Avance III NMR spectrometer equipped
with a TXI cryoprobe. Uniformly 15N/13C-labeled samples of
WT and H50Q -Syn were prepared as previously described
(35), at concentrations of 500 and 700 
M, respectively, in 10
mM sodium phosphate buffer, 100 mM NaCl, pH 7.5, 5% D2O,
0.01% NaN3, 0.001% dimethyl-silapentane-sulfonate. 1H,15N
heteronuclear single quantum coherence spectroscopy, BEST-
HNCO, BEST-iHNCO, BEST-HNCOCACB, BEST-HNCACB,
HA(CO)NH, and HNHA experiments were recorded to assign
the backboneHN,N,C, CA,CB, andHAchemical shifts of both
WT andH50Q -Syn (36, 37). All spectra were processed using
nmrPipe (38) and Collaborative Computing Project for NMR
analysis (39) and were referenced using the internal dimethyl-
silapentane-sulfonate chemical shift (40). Themeasured chem-
ical shift values ofWT andH50Q -Syn have been deposited in
the Biological Magnetic Resonance Data Bank (41). Secondary
structure populations were calculated from chemical shifts
using the 2D web server (version 1.2) (24).
RESULTS
Prediction of the Aggregation Propensity—We studied the
aggregation propensity of H50Q -Syn using the Zyggregator
method (23, 42). The effects of the His to Gln mutation on the
conformational fluctuations of -Syn were considered via the
CamP algorithm (30), which provides a prediction of transient
structure formation and solvent accessibility in different
regions of the protein. By combining solvent exposure contri-
butions and aggregation profiles (23), we found that the overall
aggregation propensity of the H50Q variant is increased by

5% comparedwithWT-Syn, from0.84 to 0.88 (Fig. 1).More
specifically, we observe an increase in aggregation propensity
for residues 35–47 (as the area below the curve increases from
12 to 15) and residues 61–96 (as the area below the curve
increases from33 to 34). Importantly, glutamine 50 is predicted
to allow exposure of the amino acid stretches around this posi-
tion, which increases the ability to establish long range interac-
tions and promote aggregation. This analysis is in agreement
with predictions of residue burial (43) and accessibility (44)
calculated by independent methods.
Kinetic Analysis of the Aggregation Process—Both WT and
H50Q -Syn aggregation time courses were measured under
physiological conditions and constant double orbital agitation
over the concentration range of 5–100 
M. Analysis of normal-
ized ThT fluorescence data (Fig. 2) shows that both proteins
form amyloid fibrils following a concentration-independent lag
phase (Fig. 2B), which is consistently shorter for the H50Q var-
FIGURE 1. Prediction of aggregation propensity of WT and H50Q -Syn.
Shown are CamP-corrected aggregation profiles of WT (black) and H50Q
-Syn (red) as calculated with the Zyggregator method (23). HX, hydrogen
exchange.
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iant of 
2-fold at each concentration except at 10 
M and,
overall, in agreement with previous results (18). Apparent
growth rates (kapp) were quantified from the same ThT data
(Fig. 2A) and confirm that H50Q -Syn aggregates faster than
WT (20) with the highest differences at 70 and 100 
M where
H50Q -Syn kapp exhibits a rate of
0.6 h1 compared with 0.1
h1 for WT -Syn.
Because patients carrying the H50Q mutation are expected
to express bothWTand variant protein, we investigated further
the aggregation kinetics of a mixture of the two species. Differ-
ent proportions of WT and H50Q -Syn were prepared, keep-
ing constant the total concentration of -Syn at 70 
M (Fig. 3).
A progressive prolongation of the lag phase is directly depen-
dent on the relative proportion of theWT over the variant (Fig.
3B), and on the contrary, the WT aggregates faster by increas-
ing the concentration of the variant (Fig. 3C).
Thermodynamic Analysis of -Syn Fibrils—Although when
examined under the electron microscope, our fibrillar aggre-
gates do not exhibit major differences (Fig. 3D), we found clear
evidence thatH50Q-Syn fibrils aremore resistant to denatur-
ation than WT. We titrated WT and H50Q -Syn fibrils with
guanidine HCl and analyzed the material in solution after 72 h
of incubation at each concentration of denaturant. Size exclu-
sion chromatography showed a single peak eluting from the
column at the same retention time as the native monomer (Fig.
4A). The fractions of the quantified soluble monomer over the
total protein concentration were fitted with the linear poly-
merization model, as described under “Experimental Proce-
dures.” These results clearly show that the fibrils formed byWT
-Syn are significantly less stable than those formed by H50Q
-Syn (Fig. 4B), with a midpoint concentration of guanidine
FIGURE 2. Kinetics of fibrillogenesis. A, normalized fluorescence data of WT
(dashed lines) and H50Q (solid lines) -Syn at six different concentrations: 100

M (gray), 70 
M (purple), 50 
M (red), 30 
M (green), 10 
M (blue), and 5 
M
(black), respectively. B, effect of initial protein concentration on the duration
of the lag phase in the aggregation of WT (open bars) and H50Q -Syn (solid
bars), respectively.C, dependenceof kapp, apparent growth rate of fibrils, over
initial monomer concentration for WT and H50Q -Syn. The bars represent
means	 S.D. of four independent experiments.
FIGURE 3.Mutual effect ofWT and H50Q-Syn on the aggregation kinetics. A, normalized data of mixtures of WT/H50Q -Syn at 1:5 (orange), 1:2 (green),
1:1 (red), 2:1 (blue), and 5:1 (black) molar ratios, respectively. Curves at 70 
M of WT (gray) and H50Q (purple) were also included. B, effect of increasing
concentration of H50Q (or WT) -Syn on the lag time of aggregation. C, effect of increasing concentration of H50Q (or WT) -Syn on the kapp of aggregation.
Means	 S.D. of at least three independent experiments are shown. D, microscopic analysis of in vitro fibrils of WT and H50Q -Syn. Scale bars, 100 nm.
FIGURE 4. Thermodynamic stability of in vitro fibrils formed by WT and
H50Q -Syn. A, size exclusion profile of ultracentrifuged samples of WT and
H50Q -Syn fibrils after denaturation with guanidine HCl. Representative
curves at 5, 2.5, and 1.25 M guanidine HCl, respectively, show a single peak
eluting at the same retention time as the nativemonomer (eitherWTorH50Q
-Syn) in PBS. Both the two isoforms show the same pattern when applied to
a Superdex 200 column equilibrated and eluted with PBS at 0.5 ml/min.
mA.U., milli absorbance units. B, the proportion of monomer released from
WT (circles) and H50Q (squares) -Syn fibrils over the total protein concentra-
tion at increasing guanidine HCl (Gdn-HCl) concentrations was analyzedwith
Equation 1 following the linear polymerization model as described under
“Experimental Procedures.” Curves shown as mean (S.D.) of three indepen-
dent experiments.
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HCl decreasing from 2.4	 0.1 M for the variant to 1.2	 0.1 M
for WT and a difference in the free energy of elongation in the
absence of denaturant, Gel0  Gel0H50Q  Gel0WT, of
5.0	 1.0 kJmol1 (Table 1). This difference corresponds to a
significant reduction in the critical concentration, i.e. in the
solubility, from 4.1	 0.1 
M forWT -Syn to 0.6	 0.2 
M for
the H50Q variant.
Accurate AFM measurements reveal that WT and H50Q
fibrils do in fact exhibit different structural details (Fig. 5).
Although in both cases fibrils are short and straight, with typi-
cal lengths ranging from 100 to 800 nm, fibrils formed byH50Q
-Syn mainly consist of rods with relatively uniform width, in
some cases exhibiting a periodic structure (Fig. 5, A–C). The
structured fibril profile appears to be symmetric and therefore
compatible with an even number of constituent subunits, in
agreement with previous findings (18), although our AFM
images suggest that these fibrils are formedby apposition of two
incomplete rods rather than from intertwining of protofila-
ments. On the contrary, there is no evidence of periodicity in
the WT -Syn fibrils. The latter result from the assembly of
different units slightly staggered along the fibril axis, giving rise
to an irregular variation of the fibril width along the fibril (Fig. 5,
D–F). The structural differences betweenWTandH50Q-Syn
fibrils are also reflected in the fibril heights, which are 5.8	 0.1
nm for H50Q -Syn and 8.3 	 0.2 nm for the WT species,
respectively. Overall, the structural features observed from
AFM data suggest a more ordered and compact packing of the
protein in H50Q -Syn fibrils compared with the WT species.
These findingsmay be correlated with the different fibril stabil-
ity observed for the variant and WT -Syn.
NMR Analysis of Residual Secondary Structure in the Disor-
dered State—Two-dimensional 1H,15N heteronuclear single
quantum coherence spectroscopy correlation spectra of -Syn
and H50Q -Syn closely overlay (Fig. 6A), thus indicating that
both proteins populate highly heterogeneous conformational
ensembles. Small amide chemical shift perturbations are found
close to the site of mutation (Fig. 6B), localized to residues
Val48–Gly51.NMRchemical shifts are highly sensitive probes of
local structure, and therefore to investigate perturbations to
residual secondary structure in the variant, we measured com-
plete sets of HN, N, C, CA, CB, and HA backbone chemical
shifts in both WT and H50Q -Syn. Chemical shift perturba-
tions in all spins were small and restricted to the vicinity of the
mutation (Fig. 6C). We then used the 2D algorithm (24) to
calculate and compare secondary structure populations in the
WT and H50Q variant (Fig. 6D). Very few residual -helical
populations are observed in either species, but polyproline II
and -sheet populations of up to 20% are found across the
length of the sequence. A 7% increase in polyproline II popula-
tion is observed around the site of the mutation in H50Q, but
otherwise the perturbations from the WT are very small.
DISCUSSION
The aggregation kinetics data discussed above are consistent
with previous reports that the H50Q mutation in the -Syn
sequence is associated with an increased aggregation propen-
sity (18–21). This mutation was independently reported in an
apparently sporadic British case and in a familial Canadian case
with British ancestry, with evidence of a founder effect (16, 17).
Oligomerization and aggregation of -Syn have long been
considered to be crucial in the pathogenesis of Parkinson dis-
FIGURE 5.AFManalysis of in vitro fibrils formedbyWTandH50Q-Syn.A–C, surface plots of topographic AFM images of H50Q-Syn fibrils.D–F, WT-Syn
fibrils.
TABLE 1
Thermodynamic parameters of guanidine HCl induced unfolding of
-synuclein fibrils
All of the values in the table are means 	 S.D. of three independent experiments.
The values are as follows: D50% (M), midpoint concentration of guanidine HCl;
Gel0 (kJ mol1), free energy of association in absence of denaturant; m (kJ mol1
M1), dependence of Gel on denaturant concentration; cc, critical concentration
(
M).
-Synuclein D50% Gel0 m cc
M kJ mol1 kJ mol1 M1 
M
WT 1.2	 0.1 30.8	 0.1 5.6	 0.5 4.1	 0.1
H50Q 2.4	 0.1 35.4	 0.9 4.5	 0.3 0.6	 0.2
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ease, although the precise toxic species remains a matter of
debate (45). Previously reported missense mutations have
accordingly generally been shown to enhance this process.
However, the picture is far from clear, and the mechanism by
which mutations modulate aggregation kinetics remains
unsolved. In this study, we have shown that the WT protein,
also expected to be expressed in all heterozygous patients, can
modulate the aggregation kinetics of the mixture of WT and
H50Q -Syn. These findings suggest that availability of data on
the intracellularmolar ratio between variant andWTprotein in
these patients would be crucial to elucidate the natural history
of the disease and interpret some unexplained heterogeneous
clinical features.
In patients with the A53T mutation, there is evidence that
the expression levels of the WT and mutant alleles may not
always be equal (46, 47). It is unknown whether the H50Q
mutation is expressed at the same levels as WT -Syn in vivo.
Interestingly, H50Q falls into a region that has been proposed
to regulate -Syn expression through a negative feedback loop
between the protein and its ownmRNA (48). H50Q is predicted
to reduce the regulatory potential of -Syn, which suggests an
increase in protein expression and an enhanced tendency to
aggregate.
Although the effect of themutation on the aggregation kinet-
ics is generally observed (18–21), the structural basis of this
pathogenic property has hitherto not been fully explained
because of the intrinsic difficulty of singling out abnormally
structured species in an ensemble of different conformers. A
comparison ofWT, H50Q, and H50Rmutations indicated that
a positive charge at residue 50 suppresses aggregation; how-
ever, the aggregation of H50A and H50D variants was slower
than H50Q, indicating that aggregation behavior is not solely
determined by electrostatic effects (19). A powerful technique
to investigate the conformation of-Synmonomers in solution
is NMR spectroscopy, and at least three studies of the H50Q
variant have recently been reported (18–20). The extent and
FIGURE 6. NMR characterization of residual structure in monomeric H50Q. A, overlay of 1H,15N heteronuclear single quantum coherence spectroscopy
spectra of WT (blue) and H50Q (red) -Syn. Arrows highlight cross-peaks that exhibit large chemical shift changes between the WT and the variant. B, amide
chemical shift differences betweenWT and H50Q -Syn, calculated as the weighted combinationNH (H
2 (N/5)
2)1⁄2. Residue 50 is highlighted with
an asterisk (*). C, chemical shift perturbations of HN, N, HA, C, CA, and CB resonances in H50Q. Glycine HA chemical shifts are reported as the averages of both
chemical shifts. D, secondary structure populations of WT (dashed lines) and H50Q (solid lines) calculated from backbone chemical shift data using the 2D
algorithm (24).
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magnitude of amide chemical shift perturbations (NH up to
0.15) that we observe here around the site of the mutation (Fig.
7B) are very similar to these other reports. However, in one case
very large chemical shift perturbations (NH 
0.5) were also
observed for residues Asp135, Tyr136, andGlu137 in the C termi-
nus of the protein (19).We have not observed evidence of these
chemical shift changes in any of our experiments, despite iden-
tical experimental conditions (10 mM sodium phosphate, 100
mM NaCl, pH 7.4, 283 K). Khalaf et al. (20) suggested that the
C-terminal chemical shift perturbations observed by Chi et al.
(19) may arise frommetal ion contamination; we also note that
multiple cross-peaks can be observed for some C-terminal res-
onances (e.g. Ala140) in the spectra of Chi et al. (19), raising the
additional possibility of degradation or other covalent modifi-
cation.Wehave not observed such additional resonances in any
of our own spectra.
Ghosh et al. (18) also reported small chemical shift perturba-
tions in the C-terminal region between residues 113 and 135, at
pH 6 in the absence of salt. As noted by Khalaf et al. (20), chem-
ical shifts in this region are highly sensitive to the electrostatic
environment and the ionic strength. NMR titration experi-
ments have shown that His50 has a pKa of 6.5–6.8 (dependent
on ionic strength) (49). Therefore at pH 6, the H50Q mutation
eliminates a positive charge, whereas at pH 6.8 (20) or physio-
logical pH 7.4, as in our study, the charge on His50 is reduced
and perturbations in the C terminus arising from the H50Q
mutation are also diminished. Khalaf et al. (20) investigated the
effect of the H50Q mutation on paramagnetic relaxation
enhancement effects arising from a nitroxide spin-label posi-
tioned at residue 20, using an engineered E20C variant. PREs
provide a sensitive probe of transient long range tertiary struc-
ture in the disordered state and previously uncovered a weak
interaction between the C-terminal region of -Syn with the
N-terminal and the 61–95 non-amyloid- component regions
(50, 51). However, the H50Q variant was not observed to per-
turb these long range PREs, indicating that the residual tertiary
structure of the variant is indistinguishable from that of theWT
(20). Khalaf et al. (20) also conducted a preliminary investiga-
tion of the residual secondary structure ofWTandH50Q-Syn
by comparison of C secondary chemical shifts in a solution of
bacterial lysate and, as measured in detail in the present study,
no significant differences were detected.
NMR chemical shift analysis represents an effective and sen-
sitive tool for understanding residual secondary structure in
disordered proteins, with the 2D method having an accuracy
of 
2% for the detection of changes in secondary structure
populations of disordered proteins (24). We have previously
applied this method (24) to characterize the secondary struc-
ture populations of -Syn expressed within living cells, using
in-cell NMR spectroscopy (52, 53), and small decreases in and
polyproline II populations (5%) were observed across the
sequence, but otherwise the proteinwas found to have the same
disordered structure as in dilute aqueous solutions. The com-
prehensive analysis of secondary structure populations in WT
and H50Q -Syn that we have presented here shows only a
small increase (7%) in the polyproline II population, specific
to the site of the mutation (Fig. 6D). By comparison, a similar
study of the A53T variant observed a 10% increase in the pop-
ulation of -structure around the site of the mutation (54). An
analysis of perturbations to secondary structure populations
measured systematically for a series of-Syn variants (55) high-
lighted that the population of -structure correlated strongly
(r  0.93) to the aggregation propensity (54). However, much
weaker correlationswere observedwith the formation of-hel-
ical (r 0.24) or polyproline II (r 0.19) structure. Given that
only eight variants were analyzed (55), the specific values of
these coefficients of correlation should be considered with cau-
tion, and further work will be needed to firmly establish the
association between the changes in the -helical or polyproline
II populations and the changes in aggregation rate.
In this context, it is notable that both  and polyproline II
secondary structures are suitable for the formation of intermo-
lecular hydrogen bonds and could thus promote aggregation.
These structured elements, if exposed, may be able to promote
FIGURE 7. Summary of factors affecting the aggregation propensity ofWT andH50Q-Syn. A, schematic free energy landscape for the elongation ofWT
and H50Q fibrils, illustrating the observed stabilization of H50Q variant fibrils and the potential stabilization of the transition state. Changes to secondary
structure populations within the monomeric ensemble are also indicated, and a fragment of -Syn H50Q (residues x-y) structure is also shown, modeled in a
polyproline II conformation.B,measuredchanges in residual secondary structure canpotentially beused to improve theaccuracyof thepredictedaggregation
profiles ofWT (black) andH50Q-Syn (red) by combining the Zyggregator profileswith the andpolyproline II secondary structure populations, Pbeta and PPP,
calculated from experimental chemical shifts (Fig. 6D): Zi
cs Zi
agg(Pi
beta Pi
PP)/(Pbeta PPP)max.
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more stable initial interactions than those established by coil
regions, leading to increased aggregation potential (Fig. 7).
Incorporating experimental measurements of  and polypro-
line II populations into calculations of aggregation propensity
may in the future be used to improve the accuracy of these
predictions. Such calculations are illustrated in Fig. 7, using
secondary structure populations determined by NMR (Fig. 6D)
togetherwith a scoring functionwith a form similar to that used
to correct for solvent exposure (Equation 4).
In addition to the perturbations to secondary structure in the
monomeric ensembles of WT and H50Q -Syn, we have also
identified a significant increase in the thermodynamic stability
of H50Q -Syn fibrils compared with theWT species,Gel
5.0 	 1.0 kJ mol1 (Fig. 7). This finding might be consistent
with some morphological differences revealed by EM (18) and
our AFM analyses, but the difficulty in determining the struc-
ture of amyloid fibrils precludes a detailed structural interpre-
tation of these differences. However, structural studies of amy-
loid fibrils are rapidly improving in resolution and scale (56),
and several solid state NMR models of the -Syn fibril core
indicate that His50 is close to the edge of a -strand or in an
adjacent loop region (57–59). The increased stability of H50Q
fibrils may therefore arise from a stabilization or extension of
this -strand within the fibril core, similar to recent observa-
tions of the core structure of A53T -Syn fibrils (60). Alterna-
tively, however, the variant may favor the formation of a fibril
polymorph with more extensive rearrangements in the core
structure, as observed for fibrils of the E46K variant (60).
It is also possible that the increased thermodynamic stability
of H50Q -Syn fibrils could contribute toward its increased
rate of aggregation. The macroscopic aggregation rate, kapp
(Fig. 2), is dependent on the microscopic rate of fibril elonga-
tion (61), which in turn depends on the free energy of the tran-
sition state, as depicted in Fig. 7. If the H50Q variant stabilizes
this state (for example, if residue 50 is partially structured in the
transition state), then this will also contribute toward the
increased rate of aggregation, alongside the perturbations to
themonomeric ensemble discussed above. Thus, it is important
in the analysis of aggregation kinetics to consider both the
fibrillar “products” of the reaction, as well as the monomeric
“reactants.”
Finally, and importantly, the increased stability of fibrils
formed from theH50Q variant corresponds to an order ofmag-
nitude reduction in the critical concentration, from 4.1 	 0.1

M for WT to 0.6 	 0.1 
M for the variant. It is worth noting
that the concentration of -Syn in synaptosomes is 
20 
M
(62). It has been previously noted that the expression levels of
proteins are finely tuned, together with their critical concentra-
tions and aggregation rates, to avoid aggregation under normal
physiological conditions (25–27). Indeed, many proteins,
including -Syn, are present in vivo at concentrations that
exceed their critical levels and therefore exist in ametastable, or
supersaturated, state in which only large kinetic barriers pre-
vent their aggregation (25–27). In this context, the lowering of
the critical concentration for the H50Q variant, particularly
together with the acceleration of its aggregation, may tip this
delicate balance toward aggregation and ultimately the onset of
disease.
In conclusion, we have presented an analysis of the modula-
tion of the aggregation process of the H50Q variant -Syn by
theWT formandof the features in their sequence and structure
that are associated with their different aggregation behavior.
Our results show that the changes in the ratio between the
concentrations of the WT and H50Q -Syn, in the secondary
structure populations of the monomeric ensemble, and in the
thermodynamic stability of the fibrils, are closely associated
with an alteration of the aggregation behavior of this protein.
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